Navigation Links
Molecular Imaging, Inc. Announces New Webinar: Advancing Discovery and Development of Biologics Through Non-Invasive Biodistribution Imaging
Date:9/5/2013

Ann Arbor, MI (PRWEB) September 05, 2013

The free webinar, which will take place on September 10, 2013 at 11am ET, will feature presentations by Patrick McConville, Chief Scientific Officer of Molecular Imaging, and Maria Vosjan of BV Cyclotron VU.

Dr. McConville will review the dual labeling and imaging strategy and related challenges. He will provide an overview of the key imaging technologies involved, and how these technologies can be accessed and used to drive key decision-making associated with assessment of biologics targeting and biodistribution. Dr. Vosjan will present an overview of immuno-PET imaging of targeting and non-invasive biodistribution. She will focus on zirconium-89 and iodine-124 PET based detection and imaging of labeled antibodies, including preclinical and clinical imaging success stories.

“In vivo biodistribution imaging studies are increasingly enhancing the discovery and development of new biologic and pharmaceutical molecules. Attendees of this webinar can expect to gain a greater understanding of the need, challenges, and execution of the imaging in these biodistribution studies including PET, SPECT, and in vivo fluorescence tomography," said Molecular Imaging CSO, Patrick McConville.

Tuesday, September 10, 2013
11am ET
Duration: 1 hour
Click here for additional information and to register.

About Molecular Imaging, Inc.
Molecular Imaging, Inc. is a specialty contract research organization (CRO) located in Ann Arbor, Michigan. Molecular Imaging employs a wide array of imaging technologies, including MRI, micro-CT, micro-PET, SPECT and optical (two-dimensional and fluorescence molecular tomography) to quantitatively assess test agent performance at anatomical, functional and molecular levels. Molecular Imaging Inc. also conducts applications research to develop and optimize the use of imaging and actively seeks collaborations to further advance imaging in the field of drug discovery.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11088655.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Janina A. Longtine, MD of the Icahn School of Medicine at Mount Sinai Elected President of the Association for Molecular Pathology
2. Dartmouth researchers develop molecular switch that changes liquid crystal colors
3. Mount Sinai and Exosome Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Unmet Medical Needs
4. Molecular Diagnostics Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
5. New study shows vitamin D-related molecular switches predict childhood bone mass
6. EurekaMag.com Publishes 64 Thousand New Animal Science References and Bibliography on Molecular Cloning
7. Molecular switch controls the destiny of self-eating cells
8. The Association for Molecular Pathology announces 2013 Leadership Award recipient
9. Abnormalities in new molecular pathway may increase breast cancer risk
10. Researchers gain new molecular-level understanding of the brains recovery after stroke
11. Molecular imaging enlists prostate enzyme to detect metastases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
Breaking Medicine Technology: